INTRODUCTION
Age-related macular degeneration (AMD) is a degenerative macular disorder most often clinically apparent after 50 years of age, characterized by certain fundal features and after exclusion of other disorders e.g. high myopia etc. Drusen (deposits of extracellular material lying between retinal pigment epithelium (RPE) and the inner collagenous zone of Bruch's membrane - Figure 1 ), hyperpigmentation and hypopigmentation ofthe RPE, without visibility of choroidal blood vessels are regarded as features of early AMD. Although drusen are the hallmark ofAMD one or more hard drusen were found in at least 95% of the aged populations assessed in the larger Caucasian studies with small hard drusen being the most common in all age groups. The two stages of late AMD include exudative/neovascular (wet) and non-exudative/geographic atrophy, GA (dry) with an 80:20 ratio being observed in the majority of AMD prevalence studies (Figures 2 and 3 respectively). Exudative inflammatory role in AMD and the development of a local inflammation model ofdrusen biogenesis.55
The extensive range of inflammatory constituents identified in drusen further support this (Table 2) . AMD has been postulated to represent another chronic age-related inflammatory disease due to the striking compositional similarities between drusen and the deposits or plaques associated with Alzheimer disease, atherosclerosis and glomerular membrane disease.56-57
The role ofangiogenesis inAMD is well documented although much remains unknown. A summary of angiogenesis in CNV is provided in Figure 6 . CNV, which represents a non-specific response to a specific stimulus in 
